Mosseri Marlio Charles 4
4 · Nuvectis Pharma, Inc. · Filed May 9, 2025
Insider Transaction Report
Form 4
Mosseri Marlio Charles
10% Owner
Transactions
- Purchase
Common Stock
2025-05-08$8.65/sh+100$865→ 2,909,032 total(indirect: By Emerald Hill Ventures SARL SPF.) - Purchase
Common Stock
2025-05-06$8.40/sh+2,340$19,656→ 2,886,461 total(indirect: By Emerald Hill Ventures SARL SPF.) - Purchase
Common Stock
2025-05-06$8.64/sh+10,104$87,299→ 2,896,565 total(indirect: By Emerald Hill Ventures SARL SPF.) - Purchase
Common Stock
2025-05-08$8.65/sh+50$433→ 2,908,932 total(indirect: By Emerald Hill Ventures SARL SPF.) - Purchase
Common Stock
2025-05-07$8.40/sh+2,703$22,705→ 2,899,268 total(indirect: By Emerald Hill Ventures SARL SPF.) - Purchase
Common Stock
2025-05-07$8.64/sh+9,614$83,065→ 2,908,882 total(indirect: By Emerald Hill Ventures SARL SPF.) - Purchase
Common Stock
2025-05-08$8.65/sh+100$865→ 2,909,132 total(indirect: By Emerald Hill Ventures SARL SPF.) - Purchase
Common Stock
2025-05-08$8.65/sh+2,400$20,760→ 2,911,532 total(indirect: By Emerald Hill Ventures SARL SPF.)
Footnotes (1)
- [F1]Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL.